• AQST Investors Have Opportunity to Lead Aquestive Therapeutics, I The National Law Review Thu, 09 Jul 2026 15:30:42 GMT
• Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8 富途牛牛 Tue, 07 Jul 2026 20:14:20 GMT
• Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism GlobeNewswire Tue, 07 Jul 2026 11:00:00 GMT
• aqst investors have opportunity to lead aquestive therapeutics, i The National Law Review Mon, 06 Jul 2026 08:05:43 GMT
• 2026-07-05 | bronstein, gewirtz & grossman, llc announces an investigation against aquestive therapeutics, inc. (aqst) and encoura... Stockhouse Sun, 05 Jul 2026 15:00:00 GMT
• aqst investors have opportunity to lead aquestive therapeutics, i The National Law Review Sun, 05 Jul 2026 06:07:44 GMT
• aqst investors have opportunity to lead aquestive therapeutics, i The National Law Review Fri, 03 Jul 2026 07:16:42 GMT
• Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Stockholders to Connect ACCESS Newswire Fri, 03 Jul 2026 03:11:17 GMT
• Aquestive Therapeutics, Inc. (AQST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm ... ACCESS Newswire Tue, 30 Jun 2026 23:47:35 GMT
• aqst investor alert: bronstein, gewirtz and grossman, llc announc The National Law Review Tue, 30 Jun 2026 19:59:56 GMT
• Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga The National Law Review Sun, 28 Jun 2026 15:28:53 GMT
• aquestive therapeutics files prospectus for 230,271 common shares scanx.trade Fri, 26 Jun 2026 20:36:49 GMT
• form s-3 aquestive therapeutics inc for: 26 june by investing.com Investing.com Canada Fri, 26 Jun 2026 20:31:29 GMT
• Aquestive Therapeutics | S-3: Registration statement for specified transactions by certain issuers Moomoo Fri, 26 Jun 2026 20:20:57 GMT
• aquestive therapeutics, inc. actuals & estimates (nasdaq:aqst) TradingView Fri, 26 Jun 2026 12:33:13 GMT
• Cantor Fitzgerald Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $11 富途牛牛 Fri, 26 Jun 2026 07:00:00 GMT
• aqst investor alert: bronstein, gewirtz and grossman, llc announc The National Law Review Thu, 25 Jun 2026 20:37:31 GMT
• lifesci capital maintains aquestive therapeutics(aqst.us) with buy rating, maintains target price $9 Moomoo Thu, 25 Jun 2026 17:32:00 GMT
• bronstein, gewirtz & grossman, llc encourages aquestive therapeut The National Law Review Thu, 25 Jun 2026 15:39:22 GMT
• Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8 Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• form 4 aquestive therapeutics inc for: 24 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 15:38:14 GMT
• Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last? Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• Aquestive Therapeutics director Julie Krop sells $125k in stock Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) institutional confidence TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• form 144 aquestive therapeutics for: 23 june by investing.com Investing.com South Africa Wed, 24 Jun 2026 01:20:23 GMT
• form 144 aquestive therapeutics for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 20:58:52 GMT
• aquestive therapeutics (aqst) reports q1 loss, beats revenue estimates MSN Tue, 23 Jun 2026 17:59:44 GMT
• 2026-06-23 | bronstein, gewirtz & grossman, llc initiates an investigation into allegations against aquestive therapeutics, inc. (... Stockhouse Tue, 23 Jun 2026 15:00:00 GMT
• With onshoring ‘having a moment,’ Aquestive CEO shares lessons from 20 years of US manufacturing BioSpace Tue, 23 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc encourages aquestive therapeutics, inc. (aqst) shareholders to inquire about securities investi... ACCESS Newswire Sun, 21 Jun 2026 22:03:59 GMT
• aquestive therapeutics (nyse:aqst): what insider activity reveals about corporate confidence Kalkine Media Thu, 18 Jun 2026 12:08:00 GMT
• Have Aquestive Therapeutics Insiders Been Selling Stock? simplywall.st Thu, 18 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 22:52:56 GMT
• aquestive therapeutics inc (aqst) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:51:56 GMT
• aquestive therapeutics inc (aqst) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 18:42:45 GMT
• aquestive therapeutics inc (aqst) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 12:21:30 GMT
• aquestive therapeutics inc (aqst) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 12:13:13 GMT
• aquestive therapeutics inc (aqst) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 11:56:25 GMT
• aquestive therapeutics ceo sells $104,010 in company stock by investing.com Investing.com South Africa Wed, 17 Jun 2026 02:42:45 GMT
• insider sell: aquestive therapeutics inc (aqst) president and ce GuruFocus Wed, 17 Jun 2026 01:21:49 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against aquestive therapeutics, inc. (aqst) and enc... ACCESS Newswire Tue, 16 Jun 2026 20:38:46 GMT
• aquestive therapeutics ceo sells $104,010 in company stock Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation aga The National Law Review Sun, 14 Jun 2026 18:35:25 GMT
• 2026-06-14 | bronstein, gewirtz & grossman, llc announces an investigation against aquestive therapeutics, inc. (aqst) and encoura... Stockhouse Sun, 14 Jun 2026 15:00:00 GMT
• Aquestive (AQST) awards Abigail Jenkins 50,500 stock options at $3.99 Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• aquestive therapeutics | 4: statement of changes in beneficial ownership of securities-director brown gregory b Moomoo Fri, 12 Jun 2026 07:00:00 GMT
• aquestive therapeutics (aqst) director receives 50,500 stock options grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc encourages aquestive therapeutics, inc. (aqst) stockholders to inquire about securities investi... ACCESS Newswire Thu, 11 Jun 2026 17:03:53 GMT
• AQST: FDA progress, global expansion, and all proposals passed with strong shareholder support TradingView Wed, 10 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation aga The National Law Review Tue, 09 Jun 2026 20:38:06 GMT
• aquestive therapeutics, inc. (aqst) investigation: bronstein, gewirtz & grossman, llc encourages shareholders to contact the firm ... ACCESS Newswire Sun, 07 Jun 2026 20:36:05 GMT
• bronstein, gewirtz & grossman, llc is investigating aquestive therapeutics, inc. (aqst) and encourages investors to connect ACCESS Newswire Thu, 04 Jun 2026 19:00:20 GMT
• 2026-06-04 | bronstein, gewirtz & grossman, llc is investigating aquestive therapeutics, inc. (aqst) and encourages investors to c... Stockhouse Thu, 04 Jun 2026 15:00:00 GMT
• Aquestive Therapeutics: Rating Downgrade Despite Probability Of Anaphylm Approval Seeking Alpha Thu, 04 Jun 2026 07:00:00 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Wed, 03 Jun 2026 07:00:00 GMT
• aqst: aquestive therapeutics - interactive chart Zacks Investment Research Tue, 02 Jun 2026 21:35:41 GMT
• bronstein, gewirtz & grossman, llc encourages aquestive therapeutics, inc. (aqst) stockholders to inquire about securities investi... ACCESS Newswire Tue, 02 Jun 2026 17:40:27 GMT
• 2026-06-02 | bronstein, gewirtz & grossman, llc encourages aquestive therapeutics, inc. (aqst) stockholders to inquire about secur... Stockhouse Tue, 02 Jun 2026 15:00:00 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against aquestive therapeutics, inc. (aqst) and enc... ACCESS Newswire Mon, 01 Jun 2026 11:22:40 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Fri, 29 May 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc is investigating aquestive therapeutics, inc. (aqst) and encourages stockholders to connect ACCESS Newswire Thu, 28 May 2026 22:34:52 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Wed, 27 May 2026 07:00:00 GMT
• aquestive therapeutics, inc. (aqst) investigation: bronstein, gew The National Law Review Wed, 27 May 2026 04:54:55 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Fri, 22 May 2026 07:00:00 GMT
• aquestive therapeutics charts cautious, liquid path forward TipRanks Wed, 20 May 2026 07:19:57 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Wed, 20 May 2026 07:00:00 GMT
• a quick look at today's ratings for aquestive therapeutics(aqst.us), with a forecast between $6 to $9 富途牛牛 Tue, 19 May 2026 13:16:11 GMT
• top executive’s sudden stock sale sparks fresh buzz around aquestive therapeutics TipRanks Tue, 19 May 2026 02:29:41 GMT
• aquestive therapeutics ceo sells $35,413 in company stock Investing.com Mon, 18 May 2026 07:00:00 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Mon, 18 May 2026 07:00:00 GMT
• aqst stock price, quote & chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Mon, 18 May 2026 07:00:00 GMT
• aquestive secures $150 million debt facility with oaktree by investing.com Investing.com Nigeria Sat, 16 May 2026 21:13:18 GMT
• aquestive targets q3 fda resubmission for anaphylm and projects >$150m cash at launch MSN Sat, 16 May 2026 19:43:07 GMT
• analysts offer insights on healthcare companies: aquestive therapeutics (aqst) and ardent health partners, inc. (ardt) The Globe and Mail Sat, 16 May 2026 15:36:00 GMT
• a quick look at today's ratings for aquestive therapeutics(aqst.us), with a forecast between $6 to $9 Moomoo Sat, 16 May 2026 07:00:00 GMT
• analysts are bullish on these healthcare stocks: aquestive therapeutics (aqst), monopar therapeutics inc (mnpr) The Globe and Mail Fri, 15 May 2026 21:12:00 GMT
• piper sandler maintains aquestive therapeutics(aqst.us) with buy rating, maintains target price $8 Moomoo Fri, 15 May 2026 18:20:39 GMT
• lake street maintains aquestive therapeutics(aqst.us) with buy rating, maintains target price $6 Moomoo Fri, 15 May 2026 18:20:39 GMT
• a. g. p. maintains aquestive therapeutics(aqst.us) with buy rating, maintains target price $9 富途牛牛 Fri, 15 May 2026 13:59:58 GMT
• analysts have made a financial statement on aquestive therapeutics, inc.'s (nasdaq:aqst) first-quarter report Moomoo Fri, 15 May 2026 13:08:45 GMT
• aquestive therapeutics, inc. (nasdaq:aqst) q1 2026 earnings call transcript Insider Monkey Fri, 15 May 2026 12:40:24 GMT
• Aquestive Says It’s on Track to Launch Anaphylm Studies for FDA Allergic Living Fri, 15 May 2026 07:00:00 GMT
• The Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Are Out And Analysts Have Published New Forecasts Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• Aquestive Therapeutics (AQST) Q1 Loss Per Share Narrows Challenging Bearish Narratives simplywall.st Fri, 15 May 2026 07:00:00 GMT
• Citizens reiterates Aquestive stock rating on Anaphylm progress Investing.com Fri, 15 May 2026 07:00:00 GMT
• aqst stock chart | aquestive therapeutics inc (nasdaq:aqst) ChartMill Fri, 15 May 2026 07:00:00 GMT
• aquestive therapeutics, inc. (aqst) q1 2026 earnings call transcript summary Moomoo Thu, 14 May 2026 15:13:51 GMT
• earnings call transcript: aquestive’s q1 2026 earnings beat forecasts, stock surges Investing.com Thu, 14 May 2026 13:20:22 GMT
• aquestive therapeutics reports first quarter 2026 financial results and provides business update Investing News Network Thu, 14 May 2026 07:00:00 GMT
• aquestive therapeutics, inc. 2026 q1 - results - earnings call presentation (nasdaq:aqst) 2026-05-14 Seeking Alpha Thu, 14 May 2026 07:00:00 GMT
• aquestive therapeutics q1 2026 earnings call: complete transcript Benzinga Thu, 14 May 2026 07:00:00 GMT
• aquestive therapeutics inc (aqst) q1 2026 earnings call highlights: revenue surge and strategic ... by gurufocus Investing.com Canada Thu, 14 May 2026 07:00:00 GMT
• aquestive therapeutics earnings beat by $0.06, revenue topped estimates Investing.com Nigeria Thu, 14 May 2026 02:18:33 GMT
• aquestive therapeutics (aqst) reports q1 loss, beats revenue estimates MSN Thu, 14 May 2026 01:35:25 GMT
• compared to estimates, aquestive therapeutics (aqst) q1 earnings: a look at key metrics MSN Thu, 14 May 2026 00:22:54 GMT
• aquestive therapeutics reports q1 eps (7c), consensus (13c) TipRanks Wed, 13 May 2026 22:17:04 GMT
• aquestive therapeutics, inc. reaffirm earnings guidance for the full year 2026 marketscreener.com Wed, 13 May 2026 20:01:00 GMT
• Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• Aquestive Therapeutics earnings beat by $0.06, revenue topped estimates Investing.com Wed, 13 May 2026 07:00:00 GMT
• AQST Financials: Income Statement, Balance Sheet & Cash Flow Stock Titan Wed, 13 May 2026 07:00:00 GMT
• aquestive therapeutics (aqst) trims q1 loss and secures $150m oaktree debt facility Stock Titan Wed, 13 May 2026 07:00:00 GMT
• aquestive therapeutics inc reports results for the quarter ended december 31 - earnings summary TradingView Wed, 13 May 2026 07:00:00 GMT
• aquestive therapeutics inc - enters five-year term loan facility of up to $150 million on may 12, 2026 - sec filing TradingView Wed, 13 May 2026 07:00:00 GMT
• brief-aquestive therapeutics, inc. q1 revenue usd 14.446 million vs. ibes estimate usd 10.9 million TradingView Wed, 13 May 2026 07:00:00 GMT
• 12 health care stocks moving in wednesday's after-market session - aquestive therapeutics (nasdaq:aqst) Benzinga Wed, 13 May 2026 07:00:00 GMT
• aquestive therapeutics completes $150mm debt refinancing with oaktree ABF Journal Wed, 13 May 2026 04:30:12 GMT
• aquestive therapeutics secures $150 million debt refinancing agreement with oaktree capital management geneonline.com Tue, 12 May 2026 23:45:10 GMT
• aquestive secures $150 million debt facility with oaktree Investing.com Tue, 12 May 2026 13:55:38 GMT
• Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• Aquestive Therapeutics Secures $150M Refinancing Deal Ahead of Potential Anaphylm Launch citybiz Tue, 12 May 2026 07:00:00 GMT
• aquestive therapeutics announces $150 million debt refinancing to support anaphylm™ launch if approved by fda Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• aquestive therapeutics inc expected to post a loss of 14 cents a share - earnings preview TradingView Mon, 11 May 2026 21:58:05 GMT
• aquestive therapeutics (aqst) eps diluted (ttm) Zacks Investment Research Sun, 10 May 2026 18:47:01 GMT
• aqst deadline reminder: bronstein, gewirtz & grossman llc reminds aquestive therapeutics, inc. investors to join the class action ... ACCESS Newswire Fri, 08 May 2026 09:14:11 GMT
• aqst deadline reminder: bronstein, gewirtz & grossman llc reminds aquestive therapeutics, inc. investors to join the class action ... ACCESS Newswire Thu, 07 May 2026 19:31:41 GMT
• aquestive therapeutics to announce q1 2026 financial results on may 13, followed by conference call on may 14 geneonline.com Wed, 06 May 2026 11:41:30 GMT
Aquestive Therapeutics, Inc(NASDAQ:AQST)

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of le...
Website: http://www.aquestive.com
Founded: 2004
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
